Double maintains 2 strategies that include IBRX - ImmunityBio, Inc.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
USDU | 0.06% | $173.44M | 0.5% |
RING | -0.06% | $1.38B | 0.39% |
TDTT | 0.10% | $2.47B | 0.18% |
SPSK | -0.24% | $307.27M | 0.5% |
JMST | 0.33% | $3.65B | 0.18% |
GLDM | 0.34% | $14.42B | 0.1% |
NEAR | 0.35% | $3.26B | 0.25% |
SHYM | -0.49% | $322.93M | 0.35% |
DBE | 0.50% | $48.48M | 0.77% |
SOYB | 0.64% | $25.54M | 0.22% |
STIP | -0.64% | $11.88B | 0.03% |
IAU | 0.71% | $45.68B | 0.25% |
VTIP | -0.75% | $14.78B | 0.03% |
BAR | 0.83% | $1.10B | 0.1749% |
IBTI | -0.85% | $995.39M | 0.07% |
SGOL | 0.93% | $5.06B | 0.17% |
GLD | 1.00% | $96.70B | 0.4% |
UGA | 1.03% | $73.47M | 0.97% |
AAAU | 1.03% | $1.47B | 0.18% |
SHY | 1.08% | $24.03B | 0.15% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
FATBB | -<0.01% | $50.77M | -11.65% | 9.83% |
VSA | -0.02% | $7.04M | -49.24% | 0.00% |
CPRI | 0.03% | $2.18B | -48.85% | 0.00% |
XGN | 0.05% | $125.45M | +203.70% | 0.00% |
GTX | 0.10% | $2.41B | +25.45% | 0.51% |
ZCMD | -0.19% | $32.45M | -11.38% | 0.00% |
PHYS.U | 0.22% | - | - | 0.00% |
CYH | 0.23% | $601.91M | +15.63% | 0.00% |
AEM | 0.24% | $53.84B | +54.79% | 1.53% |
HRTG | -0.32% | $742.60M | +160.15% | 0.00% |
NEM | -0.37% | $55.47B | +16.34% | 2.04% |
HEES | -0.38% | $3.52B | +99.54% | 1.15% |
LITB | -0.41% | $21.28M | -72.45% | 0.00% |
LUMN | -0.47% | $4.29B | +219.08% | 0.00% |
FSM | -0.61% | $1.67B | +0.18% | 0.00% |
DV | 0.62% | $2.34B | -23.73% | 0.00% |
BVN | 0.64% | $3.68B | -15.25% | 0.00% |
MUX | 0.65% | $386.55M | -32.45% | 0.00% |
PCRX | 0.65% | $1.19B | -18.76% | 0.00% |
TEF | 0.71% | $27.20B | +8.80% | 6.44% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
FMTO | -9.83% | $45.74M | -99.96% | 0.00% |
CBOE | -9.02% | $22.95B | +20.67% | 1.12% |
GFI | -8.46% | $18.61B | +31.67% | 2.75% |
SAND | -8.30% | $2.39B | +43.23% | 0.72% |
AU | -6.50% | $20.37B | +64.23% | 2.29% |
HCA | -6.16% | $92.74B | +19.46% | 0.70% |
EGO | -4.54% | $3.68B | +17.14% | 0.00% |
BTCT | -4.52% | $25.35M | +93.08% | 0.00% |
K | -4.49% | $28.49B | +32.17% | 2.77% |
EQX | -4.41% | $2.75B | +11.65% | 0.00% |
WKC | -4.30% | $1.56B | +9.79% | 2.46% |
FIGS | -4.08% | $754.24M | -20.00% | 0.00% |
IMMP | -3.99% | $289.16M | -32.19% | 0.00% |
AGI | -3.75% | $10.32B | +50.74% | 0.42% |
KGC | -3.66% | $16.92B | +75.38% | 0.89% |
SUP | -3.62% | $16.71M | -84.80% | 0.00% |
PSQH | -3.51% | $89.26M | -49.87% | 0.00% |
DRD | -3.49% | $1.23B | +63.69% | 2.01% |
VIV | -3.43% | $16.11B | +13.49% | 0.00% |
HMY | -3.41% | $9.01B | +54.87% | 1.23% |
Current Value
$2.691 Year Return
Current Value
$2.691 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 42.59% | $4.85B | 0.35% |
ARKG | 41.53% | $944.78M | 0.75% |
GNOM | 38.64% | $40.65M | 0.5% |
IBB | 38.29% | $5.22B | 0.45% |
PTH | 37.38% | $96.56M | 0.6% |
PBE | 36.83% | $214.12M | 0.58% |
PINK | 36.80% | $131.52M | 0.5% |
CPRJ | 35.99% | $48.43M | 0.69% |
IWC | 35.42% | $766.88M | 0.6% |
ERTH | 35.35% | $150.05M | 0.67% |
QCLN | 35.18% | $417.91M | 0.59% |
IWO | 35.17% | $11.36B | 0.24% |
PBW | 34.68% | $269.08M | 0.65% |
ARKK | 34.58% | $5.95B | 0.75% |
FBT | 34.12% | $994.71M | 0.56% |
KOMP | 34.03% | $2.20B | 0.2% |
IDRV | 33.66% | $151.57M | 0.47% |
RTH | 33.46% | $244.26M | 0.35% |
NUMV | 33.33% | $370.87M | 0.31% |
QQQJ | 33.29% | $610.08M | 0.15% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
RXRX | 37.83% | $1.73B | -55.31% | 0.00% |
NRIX | 36.70% | $721.19M | -38.57% | 0.00% |
OCUL | 36.22% | $1.14B | +14.35% | 0.00% |
VRA | 35.78% | $58.91M | -72.81% | 0.00% |
TWST | 35.39% | $1.80B | -35.27% | 0.00% |
EDIT | 34.71% | $116.78M | -76.32% | 0.00% |
CLRB | 34.55% | $11.69M | -92.38% | 0.00% |
KRYS | 34.06% | $3.77B | -20.42% | 0.00% |
BEAM | 34.04% | $1.73B | -27.49% | 0.00% |
VRDN | 33.78% | $1.03B | -13.74% | 0.00% |
ACRS | 33.68% | $132.10M | +3.39% | 0.00% |
ARWR | 33.59% | $2.12B | -38.64% | 0.00% |
CRSP | 33.03% | $3.14B | -34.78% | 0.00% |
PDSB | 32.97% | $61.66M | -61.76% | 0.00% |
CMI | 32.95% | $45.75B | +15.38% | 2.15% |
KALV | 32.84% | $579.68M | -3.40% | 0.00% |
VKTX | 32.74% | $3.08B | -60.32% | 0.00% |
CBRE | 32.49% | $38.83B | +41.52% | 0.00% |
DNLI | 32.47% | $2.06B | -30.04% | 0.00% |
CC | 32.44% | $1.65B | -61.76% | 6.85% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -25.55% | $109.64M | 0.85% |
BTAL | -24.90% | $361.41M | 1.43% |
TAIL | -21.31% | $140.49M | 0.59% |
IVOL | -15.28% | $353.94M | 1.02% |
TPMN | -9.45% | $31.54M | 0.65% |
FTSD | -8.63% | $212.46M | 0.25% |
ULST | -8.15% | $637.77M | 0.2% |
WEAT | -7.80% | $115.83M | 0.28% |
FXY | -7.35% | $838.61M | 0.4% |
UNG | -7.01% | $371.83M | 1.06% |
CORN | -6.33% | $49.57M | 0.2% |
SPTS | -5.68% | $5.76B | 0.03% |
IBTG | -4.89% | $1.88B | 0.07% |
UTWO | -4.45% | $387.71M | 0.15% |
XONE | -3.87% | $603.24M | 0.03% |
STPZ | -3.86% | $446.46M | 0.2% |
LDUR | -3.36% | $849.09M | 0.5% |
CTA | -2.68% | $1.05B | 0.76% |
VGSH | -2.59% | $22.38B | 0.03% |
IBTH | -2.16% | $1.53B | 0.07% |
Yahoo
As the U.S. stock market experiences a rally, with the S&P 500 and Nasdaq Composite showing gains amid easing trade tensions and favorable inflation data, investors are keenly observing high-growth sectors like technology that have been leading these upward trends. In such an environment, identifying tech stocks with strong growth potential can be crucial for investors looking to capitalize on market momentum while navigating the complexities of economic indicators and broader sentiment shifts.
Yahoo
The investors in ImmunityBio, Inc. 's ( NASDAQ:IBRX ) will be rubbing their hands together with glee today, after the...
Yahoo
CULVER CITY, Calif., May 12, 2025--ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced certain operational results following approval of the permanent J-code (J9028) in January 2025, as well as its financial results for the first-quarter ended March 31, 2025.
Finnhub
Immunitybio Inc: * IMMUNITYBIO Q1 REVENUE USD 16.517 MILLION VERSUS. IBESESTIMATEUSD 16 MILLION * IMMUNITYBIO Q1 OPERATING INCOME USD -64.429 MILLION *...
Finnhub
Immunitybio Inc: * IMMUNITYBIO Q1 REVENUE USD 16.509 MILLION VERSUS. IBESESTIMATEUSD 16 MILLION * IMMUNITYBIO Q1 OPERATING INCOME USD -64.429 MILLION *...
Finnhub
SAN DIEGO — SAN DIEGO — ImmunityBio, Inc. on Monday reported a loss of $129.6 million in its first quarter. On a per-share basis, the San Diego-based company said it had a loss of 15 cents. ...